Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Yamazaki

Showing results (51-60 of 252) with videos related to

Pageof 26
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 4, 2010
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancerTakahiro Tsushima, Shuichi Hironaka, Narikazu Boku, et al.
Investigational New Drugs|July 12, 2015
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancerToshihiko Doi, Takayuki Yoshino, Nozomu Fuse, et al.
Cancer Chemotherapy and Pharmacology|July 23, 2015
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancerTomohiro Nishina, Takeshi Kato, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 6, 2009
Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal disseminationMasako Imazawa, Takashi Kojima, Narikazu Boku, et al.
Radiation Medicine|May 24, 2006
Postmortem computed tomographic (PMCT) and postmortem magnetic resonance imaging (PMMRI) demonstration of fatal massive retroperitoneal hemorrhage caused by abdominal aortic aneurysm (AAA) ruptureAkiko Arai, Seiji Shiotani, Kentaro Yamazaki, et al.
Thoracic Cancer|June 20, 2024
Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of ageShuhei Mayanagi, Masazumi Inoue, Kazunori Tokizawa, et al.
Surgery|December 4, 2024
Clinical significance of resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasisJun Shibamoto, Katsuhisa Ohgi, Ryo Ashida, et al.
BMC Cancer|February 5, 2021
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysisSadayuki Kawai, Nozomi Takeshima, Yu Hayasaka, et al.
Japanese Journal of Clinical Oncology|April 25, 2020
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumorsKohei Shitara, Kentaro Yamazaki, Takahiro Tsushima, et al.
Japanese Journal of Clinical Oncology|May 10, 2013
KRAS mutational status in Japanese patients with colorectal cancer: results from a nationwide, multicenter, cross-sectional studyToshiaki Watanabe, Takayuki Yoshino, Hiroyuki Uetake, et al.
Pageof 26

Showing results (51-60 of 252) with videos related to

Sort By:
Pageof 26
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 4, 2010
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancerTakahiro Tsushima, Shuichi Hironaka, Narikazu Boku, et al.
Investigational New Drugs|July 12, 2015
Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancerToshihiko Doi, Takayuki Yoshino, Nozomu Fuse, et al.
Cancer Chemotherapy and Pharmacology|July 23, 2015
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancerTomohiro Nishina, Takeshi Kato, Kentaro Yamazaki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 6, 2009
Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal disseminationMasako Imazawa, Takashi Kojima, Narikazu Boku, et al.
Radiation Medicine|May 24, 2006
Postmortem computed tomographic (PMCT) and postmortem magnetic resonance imaging (PMMRI) demonstration of fatal massive retroperitoneal hemorrhage caused by abdominal aortic aneurysm (AAA) ruptureAkiko Arai, Seiji Shiotani, Kentaro Yamazaki, et al.
Thoracic Cancer|June 20, 2024
Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of ageShuhei Mayanagi, Masazumi Inoue, Kazunori Tokizawa, et al.
Surgery|December 4, 2024
Clinical significance of resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma with occult para-aortic lymph node metastasisJun Shibamoto, Katsuhisa Ohgi, Ryo Ashida, et al.
BMC Cancer|February 5, 2021
Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysisSadayuki Kawai, Nozomi Takeshima, Yu Hayasaka, et al.
Japanese Journal of Clinical Oncology|April 25, 2020
Phase I trial of the MET inhibitor tepotinib in Japanese patients with solid tumorsKohei Shitara, Kentaro Yamazaki, Takahiro Tsushima, et al.
Japanese Journal of Clinical Oncology|May 10, 2013
KRAS mutational status in Japanese patients with colorectal cancer: results from a nationwide, multicenter, cross-sectional studyToshiaki Watanabe, Takayuki Yoshino, Hiroyuki Uetake, et al.
Pageof 26